CD22 and B-cell chronic lymphocytic leukemia: Finally, according to the outcomes of the statistical analysis, the mean percentage of CD22 and FMC7 marker expression on lymphocytes from individuals diagnosed with atypical CLL exhibited a higher value, although this difference lacked statistical significance.